Prelude Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Buy |
50,100
+14,300
| +40% | +$188K | 0.06% | 364 |
|
|
2025
Q1 | $515K | Hold |
35,800
| – | – | 0.04% | 443 |
|
|
2024
Q4 | $600K | Sell |
35,800
-1,100
| -3% | -$18.4K | 0.04% | 445 |
|
|
2024
Q3 | $590K | Sell |
36,900
-32,000
| -46% | -$512K | 0.04% | 496 |
|
|
2024
Q2 | $622K | Sell |
68,900
-209
| -0.3% | -$1.89K | 0.04% | 394 |
|
|
2024
Q1 | $781K | Buy |
+69,109
| New | +$781K | 0.04% | 412 |
|
|
2022
Q2 | – | Sell |
-11,400
| Closed | -$102K | – | 1596 |
|
|
2022
Q1 | $102K | Buy |
+11,400
| New | +$102K | ﹤0.01% | 1114 |
|